Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse

被引:26
作者
Charan, S
Palmer, K
Chester, P
MireSluis, AR
Meager, A
Edington, N
机构
[1] UNIV LONDON ROYAL COLL VET SURG,DEPT PATHOL & INFECT DIS,LONDON NW1 0TU,ENGLAND
[2] NATL INST BIOL STAND,S MIMMS,HERTS,ENGLAND
关键词
D O I
10.1046/j.1365-2567.1997.00202.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Up to 21 days after exposure to live or ultraviolet-inactivated equid herpesvirus type-1 (EHV-1) autologous serum from ponies caused an immunosuppressive effect if incorporated into T-cell proliferation assays to EHV-1. The suppressive factor in the sera of ponies also inhibited T-cell response to phytohaemagglutinin. Increased levels of circulating activated transforming growth factor-beta, (TGF-beta(1)) were detected, and the suppressive activity of the serum could be reversed by antibody to TGF-beta(1). In a challenge experiment the ponies which exhibited circulating TGF-beta(1) activity succumbed to infection while the ones with similar magnitudes of T-cell responses, but no TGF-beta(1) activity, were protected. A definition of this immunosuppressive mechanism and its mode of induction must be central to the design of vaccines and to an understanding of the pathogenesis of EHV-1.
引用
收藏
页码:586 / 591
页数:6
相关论文
共 33 条
[1]  
Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78
[2]   INTERACTIONS OF T-LYMPHOCYTES AND B-LYMPHOCYTES AND MACROPHAGES IN RECOVERY FROM VIRUS-INFECTIONS [J].
ALLISON, AC .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1973, 66 (12) :1151-1154
[3]   TUMOR-PROMOTING ACTIVITY OF EPSTEIN-BARR-VIRUS-INDUCING FACTOR TRANSFORMING GROWTH-FACTOR TYPE BETA (EIF/TGF-BETA) IS DUE TO THE INDUCTION OF IRREVERSIBLE TRANSFORMATION [J].
BAUER, G ;
GOTSCHL, M ;
HOFLER, P .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (06) :881-888
[4]  
BRIDGES CG, 1986, CLIN EXP IMMUNOL, V65, P172
[5]  
BRYANS JT, 1978, J EQUINE MED SURG S1, V2, P115
[6]   TRIALS OF AN INACTIVATED EQUID HERPESVIRUS-1 VACCINE - CHALLENGE WITH A SUBTYPE-1 VIRUS [J].
BURROWS, R ;
GOODRIDGE, D ;
DENYER, MS .
VETERINARY RECORD, 1984, 114 (15) :369-374
[7]  
CHESTER PC, 1997, IN PRESS DNA SEQUENC
[8]   PROTECTION AGAINST LETHAL EQUINE HERPES-VIRUS TYPE-1 (SUBTYPE-1) INFECTION IN HAMSTERS BY IMMUNE STIMULATING COMPLEXES (ISCOMS) CONTAINING THE MAJOR VIRAL GLYCOPROTEINS [J].
COOK, RF ;
ONEILL, T ;
STRACHAN, E ;
SUNDQUIST, B ;
MUMFORD, JA .
VACCINE, 1990, 8 (05) :491-496
[9]   Anti-human cytomegalovirus activity of cytokines produced by CD4(+) T-cell clones specifically activated by IE1 peptides in vitro [J].
Davignon, JL ;
Castanie, P ;
Yorke, JA ;
Gautier, N ;
Clement, D ;
Davrinche, C .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2162-2169
[10]  
DUTTA SK, 1980, AM J VET RES, V41, P2066